Additional information
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
₹ 3200
EX1916 t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE | |||||||
Specimen: | 3 mL (2 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Clinical history is mandatory. | ||||||
Stability: |
|
||||||
Method: | Real-Time PCR | ||||||
Comment: | Samples received on holidays will be reported in the next schedule/next working day. | ||||||
Report: | Contact us to know the TAT. | ||||||
Usage: | Chromosomal rearrangements can produce tumorigenic fusion genes. This mechanism is seen in 15-25% of Leukemias, Lymphomas & Sarcomas. Fusions can be produced by translocations, inversions, or deletions. Specific gene fusions in a patient’s tumor cells have an important bearing on the management & prognosis. Detection of translocation t(1;19) in Acute Lymphoblastic leukemia (ALL) may be balanced or unbalanced. Both are associated with poor prognosis but more so if you have an unbalanced translocation. Such patients are usually children with T-ALL and require intensive chemotherapy to control the disease. | ||||||
Doctor Specialty: | Oncologist | ||||||
Disease: | Leukemia | ||||||
Components: | |||||||
Courier Charges: | 0.00 | ||||||
Home Collection: | Available (*T&C Apply) | ||||||
Department: | MOLECULAR DIAGNOSTICS | ||||||
Pre Test Information: | Clinical history is mandatory. |
a division of exult cares pvt. ltd.
Reviews
There are no reviews yet.